We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$232B
AUM Growth
-$11.7B
Cap. Flow
-$8.61B
Cap. Flow %
-3.72%
Top 10 Hldgs %
15.15%
Holding
8,641
New
725
Increased
3,226
Reduced
3,579
Closed
751

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$755M
2
AAPL icon
Apple
AAPL
+$563M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$419M
4
PEP icon
PepsiCo
PEP
+$387M
5
META icon
Meta Platforms (Facebook)
META
+$386M

Sector Composition

Rank Sector Weight
1 Technology 8.14%
2 Financials 7.54%
3 Healthcare 5.64%
4 Industrials 5.09%
5 Consumer Discretionary 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWBC
6651
DELISTED
Community West BanCshares
CWBC
$14K ﹤0.01%
1,196
-386
-24% -$4.31K
EVOL
6652
DELISTED
Evolving Systems, Inc.
EVOL
$14K ﹤0.01%
2,957
+556
+23% +$2.99K
APYX icon
6653
Apyx Medical
APYX
$171M
$13K ﹤0.01%
4,284
-3,807
-47% -$9.8K
ASPN icon
6654
Aspen Aerogels
ASPN
$518M
$13K ﹤0.01%
3,100
+1,750
+130% +$8.27K
ATHE
6655
Alterity Therapeutics
ATHE
$80.7M
$13K ﹤0.01%
608
+121
+25% +$3.24K
CCL icon
6656
PUT
Carnival Corporation Ltd
CCL
$39.7B
$13K ﹤0.01%
200
-31,800
-99% -$2.16M
CCOR icon
6657
Core Alternative Capital
CCOR
$28M
$13K ﹤0.01%
+500
New +$12.7K
CNVS icon
6658
Cineverse
CNVS
$65.6M
$13K ﹤0.01%
473
+114
+32% +$3.05K
CRD.A icon
6659
Crawford & Co Class A
CRD.A
$669M
$13K ﹤0.01%
1,620
+1,524
+1,588% +$12.7K
BGMSP
6660
DELISTED
Bio Green Med Solution Inc Preferred Stock
BGMSP
$13K ﹤0.01%
2,163
+1,593
+279% +$9.64K
CYRX icon
6661
CryoPort
CYRX
$762M
$13K ﹤0.01%
1,545
+284
+23% +$2.51K
D icon
6662
PUT
Dominion Energy
D
$59.3B
$13K ﹤0.01%
+200
New +$14.8K
DRIP icon
6663
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$114M
$13K ﹤0.01%
+3
New +$16K
ELDN icon
6664
Eledon Pharmaceuticals
ELDN
$285M
$13K ﹤0.01%
142
-64
-31% -$4.71K
INFU icon
6665
InfuSystem Holdings
INFU
$249M
$13K ﹤0.01%
4,500
-397
-8% -$933
LQDT icon
6666
Liquidity Services
LQDT
$1.31B
$13K ﹤0.01%
1,942
-4,411
-69% -$27.9K
LSCC icon
6667
Lattice Semiconductor
LSCC
$18.5B
$13K ﹤0.01%
2,413
-1,022
-30% -$6.22K
MBIO icon
6668
Mustang Bio
MBIO
$4.55M
$13K ﹤0.01%
2
-1
-33% -$8.52K
MNDO icon
6669
Mind CTI
MNDO
$20.6M
$13K ﹤0.01%
5,688
+3,781
+198% +$9.92K
NGD
6670
PUT
DELISTED
New Gold Inc
NGD
$13K ﹤0.01%
+5,000
New +$14K
NNDM
6671
Nano Dimension
NNDM
$343M
$13K ﹤0.01%
688
+514
+295% +$14.1K
NRXP icon
6672
NRX Pharmaceuticals
NRXP
$153M
$13K ﹤0.01%
+130
New +$12.7K
NTRA icon
6673
Natera
NTRA
$46.1B
$13K ﹤0.01%
1,447
-2,886
-67% -$28.3K
PRPL icon
6674
Purple Innovation
PRPL
$41.7M
$13K ﹤0.01%
+65
New +$16.8K
RFDA icon
6675
ALPS Dynamic US Dividend Advantage ETF
RFDA
$89.4M
$13K ﹤0.01%
+407
New +$13.1K

Similar funds

UBS Group's Q1 2018 Portfolio in Review

As of Q1 2018, UBS Group held 8,641 positions worth $232B, down 4.8% from $243B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $8.61B in Q1 2018, closing 751 positions and reducing 3,579 holdings. Its most notable exit was CalAtlantic Group, Inc., an estimated $60.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Nutrien worth $56.3M.

  • UBS Group's largest Q1 2018 buy was Nutrien: 1,191,668 shares worth $56.3M.
  • UBS Group added most to Comcast in Q1 2018, an estimated $488M increase.
  • UBS Group's biggest Q1 2018 reduction was UBS Group, cutting an estimated $755M.
  • UBS Group fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $60.8M.
  • UBS Group's ten largest holdings make up 15% of its $232B portfolio in Q1 2018.
  • UBS Group opened 725 new positions and closed 751 in Q1 2018.
  • UBS Group's portfolio value fell 4.8% quarter-over-quarter to $232B.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.